A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors

Clinical trial NCT06669975 · RECRUITING

Trial details

NCT number: NCT06669975
Sponsor: AP Biosciences Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-04-22
Primary completion: 2026-12-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.